Projects per year
Personal profile
Research interests
Epidemiology and control of poverty-related infectious diseases, in particular tuberculosis.
My scientific interest is in infectious diseases in resource-poor populations, specifically in multi-, inter- and transdisciplinary approaches to problems at the interface of their biomedical aspects, their socioeconomic context and control policy. I combine classical epidemiology with operational research and cost-effectiveness modeling.
My recent work focuses on tuberculosis and includes TB diagnostics, prediction of TB disease, TB vaccines and evaluation of novel interventions for TB control. My work strongly links to global policy, among others through participation in several WHO expert panels and advisory boards.
specialisation
Global Health, infectious disease epidemiology, tuberculosis, diagnostics, vaccines, evaluation of complex interventions
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Epidemiology of travel-related infections, University of Amsterdam
Award Date: 2 Feb 2002
Master, Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine
Award Date: 10 Sept 1996
Master, Doctor of Medicine, University of Amsterdam
Award Date: 15 Jul 1987
External positions
Chair, Executive Board, Amsterdam Institute for Global Health and Development
1 Jan 2016 → …
Keywords
- RZ Other systems of medicine
- Health in resource-poor settings
- RA0421 Public health. Hygiene. Preventive Medicine
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
Cobelens F.G.J.: Epidemiology and control of poverty-related infectious diseases
Cobelens, F., Bos, J., Erkens, C., Gomez Perez, G., Kapata, N., Lopez Garcia-basteiro, A., Phommasone, K., Spruijt, I. & Ssengooba, W.
1/01/2009 → …
Project: Research
-
Accelerating research and development of new vaccines against tuberculosis: a global roadmap
TB Vaccine Roadmap Stakeholder Group, 1 Apr 2022, In: The Lancet Infectious Diseases. 22, 4, p. e108-e120 13 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access27 Citations (Scopus) -
From latent to patent: rethinking prediction of tuberculosis
Cobelens, F., Kik, S., Esmail, H., Cirillo, D. M., Lienhardt, C. & Matteelli, A., 2017, In: lancet. Respiratory medicine. 5, 4, p. 243-244Research output: Contribution to journal › Editorial › Academic › peer-review
23 Citations (Scopus) -
Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial
Durovni, B., Saraceni, V., van den Hof, S., Trajman, A., Cordeiro-Santos, M., Cavalcante, S., Menezes, A. & Cobelens, F., 2014, In: PLoS medicine. 11, 12, p. e1001766Research output: Contribution to journal › Article › Academic › peer-review
103 Citations (Scopus) -
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise
Coussens, A. K., Zaidi, S. M. A., Allwood, B. W., Dewan, P. K., Gray, G., Kohli, M., Kredo, T., Marais, B. J., Marks, G. B., Martinez, L., Ruhwald, M., Scriba, T. J., Seddon, J. A., Tisile, P., Warner, D. F., Wilkinson, R. J., Esmail, H., Houben, R. M. G. J. & International Consensus for Early TB (ICE-TB) group, 2024, (E-pub ahead of print) In: The Lancet Respiratory Medicine.Research output: Contribution to journal › Review article › Academic › peer-review
1 Citation (Scopus) -
Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation
Gatechompol, S., Kerr, S. J., Cardoso, S. W., Samaneka, W., Tripathy, S., Godbole, S., Ghate, M., Kanyama, C., Nyirenda, M., Sugandhavesa, P., Machado, A., van Leth, F., Campbell, T. B., Swindlells, S., Avihingsanon, A. & Cobelens, F., 1 Jan 2024, In: AIDS. 38, 1, p. 31-38 8 p.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus)
Datasets
-
Data from: Delays and loss to follow up before treatment of drug-resistant TB following implementation of Xpert MTB/RIF in South Africa: a retrospective cohort study
Cox, H. (Creator), Dickson-Hall, L. (Creator), Ndjeka, N. (Creator), van’t Hoog, A. (Contributor), Grant, A. (Creator), Cobelens, F. (Creator), Stevens, W. (Creator) & Nicol, M. (Creator), Dryad, 20 Jan 2018
DOI: 10.5061/dryad.051h0, https://datadryad.org/stash/dataset/doi:10.5061/dryad.051h0
Dataset
-
Additional file 2: Table S1. of The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study
van't Hoog, H. A. H. (Contributor), Bergval, I. (Contributor), Tukvadze, N. (Contributor), Sengstake, S. (Contributor), Aspindzelashvili, R. (Contributor), Anthony, R. M. (Contributor) & Cobelens, F. (Contributor), Figshare, 2015
DOI: 10.6084/m9.figshare.c.3638963_d2.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_Table_S1_of_The_potential_of_a_multiplex_high-throughput_molecular_assay_for_early_detection_of_first_and_second_line_tuberculosis_drug_resistance_mutations_to_improve_infection_control_and_reduce_costs_a_decision_analytical_modeling_stu/4450817/1
Dataset
-
Data from: Delays and loss to follow up before treatment of drug-resistant TB following implementation of Xpert MTB/RIF in South Africa: a retrospective cohort study
Ndjeka, N. (Contributor), Cox, H. (Contributor), Dickson-Hall, L. (Contributor), van’t Hoog, A. (Contributor), Grant, A. (Contributor), Cobelens, F. (Contributor), Stevens, W. (Contributor) & Nicol, M. (Contributor), ZENODO, 20 Jan 2018
DOI: 10.5061/dryad.051h0, https://zenodo.org/record/5009776
Dataset
-
Additional file 2: Table S1. of The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study
van't Hoog, H. A. H. (Contributor), Bergval, I. (Contributor), Tukvadze, N. (Contributor), Sengstake, S. (Contributor), Aspindzelashvili, R. (Contributor), Anthony, R. M. (Contributor) & Cobelens, F. (Contributor), Figshare, 2015
DOI: 10.6084/m9.figshare.c.3638963_d2, https://springernature.figshare.com/articles/dataset/Additional_file_2_Table_S1_of_The_potential_of_a_multiplex_high-throughput_molecular_assay_for_early_detection_of_first_and_second_line_tuberculosis_drug_resistance_mutations_to_improve_infection_control_and_reduce_costs_a_decision_analytical_modeling_stu/4450817
Dataset
-
Additional file 1: of Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients
Ssengooba, W. (Creator), de Jong, B. C. (Contributor), Joloba, M. L. (Creator), Cobelens, F. (Creator), Meehan, C. J. (Creator), Jong, B. D. (Creator) & Joloba, M. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3628319_d1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Whole_genome_sequencing_reveals_mycobacterial_microevolution_among_concurrent_isolates_from_sputum_and_blood_in_HIV_infected_TB_patients/4415600
Dataset